Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Stanley Black & Decker, Inc. — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Stanley Black & Decker, Inc. trades at $90.48 (market cap $13.70B). The key difference: Stanley Black & Decker, Inc. is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays a 3.7% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Stanley Black & Decker, Inc. for 62 Days on average.
| KYMR | SWK | |
|---|---|---|
Market Cap | $8.87B | $13.70B |
Volume | 779,107 | 1,098,669 |
Sector | Health | Industrials |
52-Week High | $127.31 | $104.00 |
52-Week Low | $55.80 | $62.12 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $8.26B | $17.86B |
Dividend Yield | — | 3.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stanley Black & Decker (SWK) trades at $90.29, up 1.85% today, with a bearish technical signal from moving averages despite recent earnings beats. The company shows improving profitability with a net income margin of 4.07% in 2025, and revenue is projected to grow to $15.2B in 2026. Recent news highlights product launches like the dustbuster mini and management's focus on margin gains and brand strength.
The outlook is cautiously optimistic with a consensus price target of $93.00, offering modest upside. Key risks include competitive pressures and execution challenges, but strong institutional buying and a dividend history support long-term value. Investors should weigh improving fundamentals against near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
